Psilocybin in psychiatry: Current clinical evidence, mechanisms of action and translational perspectives. A literature review based on PubMed-indexed studies
Pharmacotherapy in Psychiatry and Neurology · 2026
DOI: 10.17219/fpn/237077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2026. Verfasst von Bartosz Nadolski und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nadolski, B., Poćwiardowski, W., Łazarz, S., & Gromniak-Haniecka, E. (2026). Psilocybin in psychiatry: Current clinical evidence, mechanisms of action and translational perspectives. A literature review based on PubMed-indexed studies. Pharmacotherapy in Psychiatry and Neurology. https://doi.org/10.17219/fpn/237077
Vancouver
Nadolski B, Poćwiardowski W, Łazarz S, Gromniak-Haniecka E. Psilocybin in psychiatry: Current clinical evidence, mechanisms of action and translational perspectives. A literature review based on PubMed-indexed studies. Pharmacotherapy in Psychiatry and Neurology. 2026. doi:10.17219/fpn/237077
BibTeX
@article{Nadolski2026,
author = {Nadolski, Bartosz and Poćwiardowski, Wojciech and Łazarz, Sonia and Gromniak-Haniecka, Ewa},
title = {Psilocybin in psychiatry: Current clinical evidence, mechanisms of action and translational perspectives. A literature review based on PubMed-indexed studies},
journal = {Pharmacotherapy in Psychiatry and Neurology},
year = {2026},
doi = {10.17219/fpn/237077}
}
EUVIMED